Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy
Blood Adv
.
2024 Nov 20:bloodadvances.2024014518.
doi: 10.1182/bloodadvances.2024014518.
Online ahead of print.
Authors
Barbara D Friedes
1
,
Amanda M DiNofia
2
,
Emma Iannone
1
,
Yimei Li
3
,
Susan R Rheingold
4
,
Allison Barz Leahy
1
,
Lisa Wray
1
,
Colleen Callahan
4
,
Diane Baniewicz
4
,
Lauren Vernau
1
,
Kelly D Getz
5
,
Richard Aplenc
4
,
Shannon L Maude
1
,
Stephan A Grupp
4
,
Regina M Myers
1
Affiliations
1
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States.
2
Children's hospital of Philadelphia, philadelphia, Pennsylvania, United States.
3
Perelman School of Medicine at the University of Pennsylvania/Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States.
4
The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States.
5
Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States.
PMID:
39565957
DOI:
10.1182/bloodadvances.2024014518
No abstract available